|
Volumn 31, Issue 1-2, 1999, Pages 494-495
|
Treatment of severe recurrent hepatitis C after liver transplantation with ribavirin plus interferon alpha
a a a b a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALPHA INTERFERON;
ASPARTATE AMINOTRANSFERASE;
AZATHIOPRINE;
BILIRUBIN;
CYCLOSPORIN;
ERYTHROPOIETIN;
METHYLPREDNISOLONE;
RECOMBINANT ALPHA2A INTERFERON;
RIBAVIRIN;
STEROID;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ADULT;
ANEMIA;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG MIXTURE;
DRUG SAFETY;
FATIGUE;
FEMALE;
FLU LIKE SYNDROME;
GRAFT REJECTION;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
HYPERURICEMIA;
LEUKOPENIA;
LIVER TRANSPLANTATION;
MALE;
ORAL DRUG ADMINISTRATION;
PARESTHESIA;
POSTOPERATIVE INFECTION;
PRIORITY JOURNAL;
RECURRENT INFECTION;
SUBCUTANEOUS DRUG ADMINISTRATION;
ADULT;
ANEMIA;
ANTIVIRAL AGENTS;
BLOOD TRANSFUSION;
DNA, VIRAL;
DRUG THERAPY, COMBINATION;
FEMALE;
GRAFT REJECTION;
HEPATITIS C;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INTERFERON-ALPHA;
LIVER FUNCTION TESTS;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
POLYMERASE CHAIN REACTION;
POSTOPERATIVE COMPLICATIONS;
RECURRENCE;
RIBAVIRIN;
|
EID: 0033056569
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)01725-4 Document Type: Conference Paper |
Times cited : (29)
|
References (5)
|